Literature DB >> 16372137

A novel Wiskott-Aldrich syndrome protein (WASP) complex mutation identified in a WAS patient results in an aberrant product at the C-terminus from two transcripts with unusual polyA signals.

Nuria Andreu1, Maricruz García-Rodríguez2, Victor Volpini3, Cecilia Frecha4, Ignacio J Molina4, Gumersindo Fontan2, Cristina Fillat5.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by immunodeficiency, thrombocytopenia and eczema. A broad spectrum of mutations in the WASP gene has been identified as causing the disease. In the present paper, we report on a patient affected by WAS with a novel complex mutation, characterized by a small 9 bp deletion followed by an inversion of 151 bp and a gross deletion of 4.3 kb within the Xp11.23 region. The small deletion and the inverted fragment are found in intron 11. The large deletion initiates downstream of exon 11 of the WASP gene, including exon 12, and a genomic region upstream of the promoter of the contiguous SUV39H1 gene. Expression studies of the mRNA of the patient's sample showed the presence of two aberrant transcripts that code for a protein of 519 amino acids. We demonstrate that these two transcripts differ in the 3' UTR region, and result from the use of two alternative polyadenylation signals. The severe phenotype of the patient correlates with the presence of an aberrant protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372137     DOI: 10.1007/s10038-005-0328-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

1.  Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich syndrome.

Authors:  C Fillat; T Español; M Oset; M Ferrando; X Estivill; V Volpini
Journal:  Am J Med Genet       Date:  2001-04-22

Review 2.  Mechanism and regulation of mRNA polyadenylation.

Authors:  D F Colgan; J L Manley
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

3.  X-linked Wiskott-Aldrich syndrome in a girl.

Authors:  O Parolini; G Ressmann; O A Haas; J Pawlowsky; H Gadner; W Knapp; W Holter
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 4.  The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.

Authors:  S B Snapper; F S Rosen
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

5.  Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences.

Authors:  F Martín; M Ga Toscano; M Blundell; C Frecha; G K Srivastava; M Santamaría; A J Thrasher; I J Molina
Journal:  Gene Ther       Date:  2005-04       Impact factor: 5.250

6.  Identification and characterization of a novel splice-site mutation in a patient with Wiskott-Aldrich syndrome.

Authors:  Nuria Andreu; Carmen Carreras; Félix Prieto; Xavier Estivill; Victor Volpini; Cristina Fillat
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

7.  Clinical course of patients with WASP gene mutations.

Authors:  Kohsuke Imai; Tomohiro Morio; Yi Zhu; Yinzhu Jin; Sukeyuki Itoh; Michiko Kajiwara; Jun-Ichi Yata; Shuki Mizutani; Hans D Ochs; Shigeaki Nonoyama
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

8.  The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene.

Authors:  Q Zhu; M Zhang; R M Blaese; J M Derry; A Junker; U Francke; S H Chen; H D Ochs
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

9.  Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

Authors:  Yinzhu Jin; Cinzia Mazza; Jacinda R Christie; Silvia Giliani; Maurilia Fiorini; Patrizia Mella; Francesca Gandellini; Donn M Stewart; Qili Zhu; David L Nelson; Luigi D Notarangelo; Hans D Ochs
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

10.  X-linked thrombocytopenia in a girl.

Authors:  Hirokazu Inoue; Hidemitsu Kurosawa; Shigeaki Nonoyama; Kohsuke Imai; Hisami Kumazaki; Takayuki Matsunaga; Yuya Sato; Kenichi Sugita; Mitsuoki Eguchi
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

View more
  6 in total

Review 1.  Implications of polyadenylation in health and disease.

Authors:  Ana Curinha; Sandra Oliveira Braz; Isabel Pereira-Castro; Andrea Cruz; Alexandra Moreira
Journal:  Nucleus       Date:  2014-10-31       Impact factor: 4.197

2.  Detection of novel 3' untranslated region extensions with 3' expression microarrays.

Authors:  Lieven Thorrez; Leon-Charles Tranchevent; Hui Ju Chang; Yves Moreau; Frans Schuit
Journal:  BMC Genomics       Date:  2010-03-26       Impact factor: 3.969

3.  The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.

Authors:  Ophélie Philipot; Véronique Joliot; Ouardia Ait-Mohamed; Céline Pellentz; Philippe Robin; Lauriane Fritsch; Slimane Ait-Si-Ali
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 4.  Alternative cleavage and polyadenylation in health and disease.

Authors:  Andreas J Gruber; Mihaela Zavolan
Journal:  Nat Rev Genet       Date:  2019-07-02       Impact factor: 53.242

5.  The lavender plumage colour in Japanese quail is associated with a complex mutation in the region of MLPH that is related to differences in growth, feed consumption and body temperature.

Authors:  Bertrand Bed'hom; Mohsen Vaez; Jean-Luc Coville; David Gourichon; Olivier Chastel; Sarah Follett; Terry Burke; Francis Minvielle
Journal:  BMC Genomics       Date:  2012-08-31       Impact factor: 3.969

Review 6.  Emerging Roles of RNA 3'-end Cleavage and Polyadenylation in Pathogenesis, Diagnosis and Therapy of Human Disorders.

Authors:  Jamie Nourse; Stefano Spada; Sven Danckwardt
Journal:  Biomolecules       Date:  2020-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.